Zhuhai United Laboratories Receives FDA Warning Letter
The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent 27 June to China-based Zhuhai United Laboratories Co. for significant deviations from CGMP for active pharmaceutical ingredients (API).
NEW DELHI: The Indian government has issued showcause notices to, and may soon blacklist, eight Chinese pharmaceutical companies found to be supplying poor quality raw material to drug manufacturers in this country.
China`s Zhuhai United Laboratories fails EDQM Inspection
Chinese drugmaker to build $60M API plant